Clinical guidelines & publications library
Guidance and publications produced by the RANZCP. Filter by type, topic, date or category.
- 
                    
Pricing Framework for Australian Public Hospital Services 2024–25Health service standards RANZCP Submission to the Independent Health and Age Care Pricing Authority (IHACPA) on Pricing Framework for Australian Public Hospital Services 2024–25. PDF Submission Submission- Last updated: Jul 2023
- Published in Australia
 - Current
 
- 
                    
Strategy towards elimination of seclusion and restraintSeclusion and restraint RANZCP Victorian Branch Submission to Victorian Department of Health on the Strategy towards elimination of seclusion and restraint PDF Submission Submission- Last updated: Jul 2023
- Published in Victoria
 - Current
 
- 
                    
Survey on NRHA priorities for 2023-2024Workforce RANZCP submission to National Rural Health Alliance (NRHA) on NRHA priorities for 2023-2024 PDF Submission Submission- Last updated: Jul 2023
- Published in Australia
 - Current
 
- 
                    
Victoria’s proposed health records regulations 2023RANZCP Victoria Branch submission to the Victorian Department of Health on the Proposed Health Records Regulations 2023 Submission- Last updated: Jul 2023
- Published in Victoria
 - Current
 
- 
                    
Consultation on methylphenidate to include early access to the Ritalin LA preparationsADHD Submission to Pharmac regarding consultation on methylphenidate to include early access to the Ritalin LA preparations. PDF Submission Submission- Last updated: Jun 2023
- Published in New Zealand
 - Current
 
- 
                    
Deep sleep therapyHistorical practices Position Statement 34: Deep Sleep Therapy was rescinded in June 2023. 
 Position statement- Last updated: Jun 2023
- Published in Australia
 - B202 3/5 R17
- Rescinded
 
- 
                    
Therapeutic use of MDMA for PTSD and psilocybin for treatment resistant depressionEthics, Professionalism, Psychedelics Information for psychiatrists about psychedelic-assisted therapy with MDMA and psilocybin. PDF Clinical guideline Clinical guideline- Last updated: Jun 2023
- Published in Australia
 
- 
                    
Therapeutic use of psychedelic substancesPsychedelics Information for psychiatrists about the potential utility of psychedelic substances to assist in treating mental illness. PDF Clinical guideline Clinical guideline- Last updated: Jun 2023
- Published in Australia
 
- 
                    
Inquiry into Assessment and support services for people with ADHDSubmission to the Senate Standing Committee on Community Affairs’ Inquiry into the Barriers to consistent, timely and best practice assessment of attention deficit hyperactivity disorder (ADHD) and support services for people with ADHD. PDF Submission Submission- Last updated: Jun 2023
- Published in Australia
 - Current
 
- 
                    
Vision 2023 and Beyond Aotearoa New ZealandRANZCP Submission to the Royal Australian and New Zealand College of Ophthalmologist on Vision 2023 and Beyond Aotearoa New Zealand. PDF Submission Submission- Last updated: Jun 2023
- Published in Aotearoa New Zealand
 - Current
 
- 
                    
Consultation on the special authority criteria for the class B stimulantsADHD Submission to Pharmac regarding the special authority criteria for the class B stimulants prescriptions in Aotearoa. 
 PDF SubmissionSubmission- Last updated: Jun 2023
- Published in New Zealand
 - Current
 
- 
                    
Consultation on New Zealand’s Telehealth draft statementGPs and psychiatrists RANZCP submission to the Medical Council of New Zealand’s (the Council) regarding consultation on the Telehealth draft statement. PDF Submission Submission- Last updated: Jun 2023
- Published in New Zealand
 - Current
 
- 
                    
Dementia - antipsychotic medications to care for people with behavioural and psychological symptomsAddressing health inequity, Dementia, Professionalism Best practices when considering the use of antipsychotic medications to care for people with behavioural and psychological symptoms of dementia (BPSD). Position statement- Last updated: May 2023
- Published in Australia
 - PS #112
 
- 
                    
Early Years Strategy Discussion Paper ConsultationChildren & adolescents Submission to the Australian Government Department of Social Services (DSS) PDF Submission Submission- Last updated: Apr 2023
- Published in Australia
 
- 
                    
Safe access to opioids consultationOpioids RANZCP submission to Manatū Hauora, Ministry of Health on the Safe Access to Opioids Consultation. PDF Submission Submission- Last updated: Apr 2023
- Published in New Zealand
 - Current
 
- 
                    
Recognition of Aboriginal and Torres Strait Islander peoples in the Australian ConstitutionAboriginal and Torres Strait Islander, Culturally safe practice The RANZCP calls for reform of the Australian Constitution to support the mental health and human rights of Aboriginal and Torres Strait Islander peoples. Position statement- Last updated: Apr 2023
- Published in Australia
 - PS #68
 
- 
                    
Raise the Age CampaignRANZCP participation in the open letter to Standing Council of Attorney General regarding the National Raise the Age Campaign PDF Submission Submission- Last updated: Apr 2023
- Published in Australia
 - Current
 
- 
                    
ADHD across the lifespanADHD, Professionalism Attention Deficit Hyperactivity Disorder (ADHD) is a major mental disorder. This statement presents principles to develop a more appropriate, accessible, equitable health system that caters for the needs of people with ADHD across their lifespan. Position statement- Last updated: Mar 2023
- Published in Australia
 - PS #55
 
- 
                    
NSW mental health system on the brink: evidence from the frontlineProfessionalism, Workforce PDF Report Report- Last updated: Mar 2023
- Published in New South Wales
 
